(19)
(11) EP 1 357 966 B8

(12) CORRECTED EUROPEAN PATENT SPECIFICATION
Note: Bibliography reflects the latest situation

(15) Correction information:
Corrected version no 1 (W1 B1)

(48) Corrigendum issued on:
05.09.2018 Bulletin 2018/36

(45) Mention of the grant of the patent:
15.06.2005 Bulletin 2005/24

(21) Application number: 02716155.3

(22) Date of filing: 24.01.2002
(51) International Patent Classification (IPC): 
A61M 15/00(2006.01)
 F16K 7/06(2006.01)
(86) International application number:
PCT/GB2002/000297
(87) International publication number:
WO 2002/058772 (01.08.2002 Gazette 2002/31)

(54)

DISPENSER

SPENDER

DISTRIBUTEUR

(84) Designated Contracting States:
AT BE CH CY DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE TR

(30) Priority: 25.01.2001 GB 0101944

(43) Date of publication of application:
05.11.2003 Bulletin 2003/45

(73) Proprietor: Clinical Designs Limited
Cambridge CB4 0AB (GB)

(72) Inventor:
  • Bacon, Raymond John
    Emsworth, Hampshire PO10 8QT (GB)

(74) Representative: Brooks, Nigel Samuel 
Hill Hampton East Meon
Petersfield, Hampshire GU32 1QN
Petersfield, Hampshire GU32 1QN (GB)


(56) References cited: : 
WO-A-98/41254
GB-A- 2 263 873
 GB-A- 1 012 565
   
       
    Note: Within nine months from the publication of the mention of the grant of the European patent, any person may give notice to the European Patent Office of opposition to the European patent granted. Notice of opposition shall be filed in a written reasoned statement. It shall not be deemed to have been filed until the opposition fee has been paid. (Art. 99(1) European Patent Convention).